In 2011, China's total import and export of medical devices is expected to exceed 25 billion U.S. dollars

Posted on

Business Club March 24 News Customs statistics: In 2010, China's total import and export of medical devices reached US$22.656 billion, an increase of 23.47% year-on-year. Among them, the export value was 14.699 billion US dollars, an increase of 20.05%; the import amount was 7.957 billion US dollars, an increase of 30.35%. Exports and imports also created the highest historical record at the same time, and the import growth rate was 10.3 percentage points higher than the export growth rate. Overall, China's foreign trade in medical devices continued to maintain a large surplus in 2010, with a cumulative trade surplus of US$6.742 billion.
At present, the global Pharmaceutical and medical device consumption ratio is about 10:7, while developed countries and regions such as Europe, the United States, and Japan have reached 1:1.02, and the global medical device market has accounted for 42% of the global pharmaceutical market. There is an expanding trend. The total output value of China's medical device industry exceeded the RMB 100 billion mark for the first time in 2010, and the production scale of many medical device products ranks first in the world. In 2010, China's monthly average export value of medical device products was 1.225 billion U.S. dollars, of which exports in November and December each exceeded 1.4 billion U.S. dollars, indicating that the international market has become increasingly dependent on China's medical device products.
At the same time, China’s medical equipment imports have also grown by more than 30% in 2010, indicating that domestic demand in China’s medical and health sector is still strong, which has driven the rapid growth of medical equipment exports from other international economies and contributed to the development of the world’s medical device trade. . In 2010, China's imports of medical devices to Europe accounted for 38.49% of China's total medical device imports in the same period. The United States accounted for 29.967%, Germany accounted for 17.45%, and Japan accounted for 16.48%.
According to Cao Gang, medical equipment of China Medical Insurance Association, the growth rate of China's medical device import and export has basically recovered to the level before the international financial crisis in 2010, but the imbalance in medical equipment import and export trade is still prominent. Looking ahead to 2011, with the shortage of global resources and expected inflation of the domestic economy, raw and auxiliary materials and power prices for grain, cotton, chemical products, water, electricity, gas, etc. are showing upward momentum, which may lead to production activities of some enterprises. Interruption, and can not be delivered to foreign customers in a timely manner. The labor cost of enterprises has generally increased by 10% to 20% over the previous year, which will also result in the transfer of some international orders to ASEAN regions and countries with lower labor costs. For China's medical device companies that are generally settled in U.S. dollars, due to their long-term dependence on exchange rate spreads and their generally small profit margins, the continuous appreciation of the renminbi will undoubtedly bring about large losses, and future industry competition and export quotation risks will Will be higher. In 2011, the expansion of imports will be the focus of balanced trade in China's medical device import and export industry, and the government will introduce some policies and measures to encourage imports.
According to the analysis of professional staff of the China Medicare Association, if China's medical device products can maintain the current international market share and expand in 2011, the annual export is expected to achieve a 15% growth, the import growth rate will be higher than exports, and the trade surplus is expected to shrink . It is estimated that the total import and export of medical devices in China is expected to exceed 25 billion U.S. dollars in 2011.

Diabetes is a group of metabolic diseases characterized by high blood sugar. Hyperglycemia is due to insulin secretion defects or their biological effects of damage, or both caused. Hyperglycemia in long-term diabetes, leading to various tissues, especially the eyes, kidneys, heart, blood vessels, nerve chronic damage, dysfunction. The etiology of diabetes is roughly one is Genetic factors. Type 1 or type 2 diabetes had significant genetic heterogeneity. There is a family history of Diabetes Mellitus, 1/4 ~ 1/2 patients with family history of diabetes. Clinically at least 60 kinds of genetic syndromes may be associated with diabetes. Second, Environmental factors, eating too much, reduce physical activity caused by obesity is the most important environmental factors of type 2 diabetes, so that type 2 diabetes genetic susceptibility to individuals prone to disease. There is no cure for diabetes, but through a variety of treatment can control diabetes. Mainly includes five aspects: diabetes education, self-monitoring of blood sugar, diet therapy, exercise therapy and drug treatment. Antidiabetic drugs are needed in the patient after eating and exercise therapy and diabetes health education, blood sugar control can not be achieved when the target treatment. Most antidiabetic drugs have a greater side effect, so the patient must follow the doctor's instructions. With the succession of new antidiabetic drug patents,the patient is not only actually reducing the cost of treatment, but also increased the number of treatment options, Take greater hopes to patients with disease control.

Anti-Diabetes

Anti-Diabetes Intermediate,Diabetes Mellitus,Diabetic Drugs,Newer Antidiabetic Drugs

Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com